Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 34, Issue 1, Pages 562-576Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14756366.2018.1532418
Keywords
Ibuprofen amides; FAAH inhibition; fatty acid amide hydrolase; endocannabinoids; induced fit docking
Funding
- Regione Autonoma della Sardegna Project L.R. 7/2007 [2012_CRP-59473]
- University of Cagliari [grant FIR 2016-17]
- Swedish Research Council [12158]
- Research Funds of Umea University Medical Faculty
Ask authors/readers for more resources
Fatty Acid Amide Hydrolase (FAAH) is a serine hydrolase that plays a key role in controlling endogenous levels of endocannabinoids. FAAH inhibition is considered a powerful approach to enhance the endocannabinoid signalling, and therefore it has been largely studied as a potential target for the treatment of neurological disorders such as anxiety or depression, or of inflammatory processes. We present two novel series of amide derivatives of ibuprofen designed as analogues of our reference FAAH inhibitor Ibu-AM5 to further explore its structure-activity relationships. In the new amides, the 2-methylpyridine moiety of Ibu-AM5 was substituted by benzylamino and piperazinoaryl moieties. The obtained benzylamides and piperazinoarylamides showed FAAH inhibition ranging from the low to high micromolar potency. The binding of the new amides in the active site of FAAH, estimated using the induced fit protocol, indicated arylpiperazinoamides binding the ACB channel and the cytosolic port, and benzylamides binding the ACB channel.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available